St Jude Medical Inc's Revenue in the fiscal year 2015 $ 5,541.00 millions
St Jude Medical Inc's Revenue in the fiscal year 2014 $ 5,622.00 millions
St Jude Medical Inc's Revenue in the fiscal year 2013 $ 5,501.00 millions
St Jude Medical Inc's Revenue in the fiscal year 2012 $ 5,503.00 millions
St Jude Medical Inc's Revenue in the fiscal year 2011 $ 5,611.70 millions
STJ Revenue third quarter 2016 Y/Y Growth Comment
St Jude Medical Inc achieved in the third quarter 2016, above Company average Revenue increase of 11.95% year on year, to $ 1,499.00 millions.
Looking into third quarter 2016 results within Medical Equipment & Supplies industry 72 other companies have achieved higher Revenue growth. While St Jude Medical Inc' s Revenue growth of 11.95% ranks overall at the positon no. 1269 in the third quarter 2016.
Revenue by Quarter for the Fiscal Years 2013, 2014, 2015, 2016
St Jude Medical Inc's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
12.37 %
2.22 %
-6.53 %
(June 30. 2008)
STJ's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2016 St Jude Medical Inc disclosed fall in Revenue from the second quarter by -4.03% to $ 1,499.00 millions, from $ 1,562.00 millions achived in the previous reporting period.
But that's not important problem, as St Jude Medical Inc's Revenue generally seem to plunge in this quarter.
Within Medical Equipment & Supplies industry 102 other companies have achieved higher Revenue quarter on quarter growth. While St Jude Medical Inc's Revenue growth quarter on quarter, overall rank is 2839.
In the III. Quarter 2016 St Jude Medical Inc disclosed fall in Revenue from the second quarter by -4.03% to $ 1,499.00 millions, from $ 1,562.00 millions achived in the previous reporting period.
But that's not important problem, as St Jude Medical Inc's Revenue generally seem to plunge in this quarter.
Within Medical Equipment & Supplies industry 102 other companies have achieved higher Revenue quarter on quarter growth. While St Jude Medical Inc's Revenue growth quarter on quarter, overall rank is 2839.
St Jude Medical Inc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Oct 01 2016)
12 Months Ending (Jul 02 2016)
12 Months Ending (Apr 02 2016)
12 Months Ending (Jan 02 2016)
12 Months Ending (Oct 03 2015)
Cumulative Revenue 12 Months Ending
$ 5,956.00
$ 5,796.00
$ 5,644.00
$ 5,541.00
$ 5,533.00
Y / Y Revenue Growth (TTM)
7.65 %
4.13 %
0.71 %
-1.44 %
-1.28 %
Year on Year Revenue Growth Overall
Ranking
# 1719
# 0
# 0
# 0
# 0
Seqeuential Revenue Change (TTM)
2.76 %
2.69 %
1.86 %
0.14 %
-0.59 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 1757
# 0
# 0
# 0
# 1634
Cumulative Revenue growth Comment
Although St Jude Medical Inc's Annual Revenue growth year on year were below company's average 8.48% , Revenue announced in the Oct 01 2016 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 7.65% year on year, from 4.13% in Jul 02 2016.
In the Healthcare sector 240 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1719.
Although St Jude Medical Inc's Annual Revenue growth year on year were below company's average 8.48% , Revenue announced in the Oct 01 2016 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 7.65% year on year, from 4.13% in Jul 02 2016.
In the Healthcare sector 240 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1719.
About St Jude Medical Inc Revenue Growth Rates (STJ), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
17.05%